1h Free Analyst Time
The publisher has been monitoring the diabetes management devices market and it is poised to grow by USD 14.31 billion during 2021-2025, progressing at a CAGR of over 8% during the forecast period. The report on the diabetes management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes and favorable government initiatives. In addition, the rising global burden of diabetes is anticipated to boost the growth of the market as well.
The diabetes management devices market analysis includes the product segmentation and geographic landscape.
The diabetes management devices market is segmented as below:
By Product
- Blood glucose monitoring devices
- Insulin delivery systems
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies the growing demand for advanced insulin delivery devices as one of the prime reasons driving the diabetes management devices market growth during the next few years.
The report on diabetes management devices market covers the following areas:
- Diabetes management devices market sizing
- Diabetes management devices market forecast
- Diabetes management devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetes management devices market vendors that include Abbott Laboratories, B. Braun Melsungen AG, Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, Novo Nordisk AS, and PHC Holdings Corp. Also, the diabetes management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global diabetes management devices market: Abbott Laboratories, B. Braun Melsungen AG, Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, Novo Nordisk AS, and PHC Holdings Corp.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the growing demand for advanced insulin delivery devices.'
According to the report, one of the major drivers for this market is the rising global burden of diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- B. Braun Melsungen AG
- Bionime Corp.
- Dexcom Inc.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- LifeScan IP Holdings LLC
- Medtronic Plc
- Novo Nordisk AS
- PHC Holdings Corp.